Intelligent Bio Solutions Stock Total Debt

INBS Stock

USD 1.51 0.04 2.58%

Intelligent Bio Solutions fundamentals help investors to digest information that contributes to Intelligent Bio's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Bio stock.

Short Long Term Debt Total Total Assets

Total Debt To Capitalization is likely to gain to 0.09 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Intelligent Bio Solutions Company Total Debt Analysis

Intelligent Bio's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Intelligent Bio Total Debt

871.44 K

Most of Intelligent Bio's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Bio Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Intelligent Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as Total Debt. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Deferred Long Term Liab	Property Plant Equipment	Long Term Debt	Short Term Investments	Intangible Assets
Total Assets		0.97	-0.95	-0.78	0.8	-0.26	0.96	-0.86	-0.13	0.93	0.95	0.95	-0.92	-0.91	0.93	0.55	-0.32	0.5	-0.32	-0.32	-0.35
Total Stockholder Equity	0.97		-0.96	-0.85	0.77	-0.41	0.93	-0.89	-0.18	0.9	0.92	0.99	-0.96	-0.95	0.91	0.67	-0.52	0.55	-0.52	-0.52	-0.54
Net Debt	-0.95	-0.96		0.7	-0.69	0.34	-0.96	0.9	0.26	-0.97	-0.91	-0.95	0.9	0.89	-0.97	-0.64	0.39	-0.35	0.39	0.39	0.41
Retained Earnings	-0.78	-0.85	0.7		-0.65	0.48	-0.66	0.74	-0.01	-0.59	-0.76	-0.86	0.91	0.89	-0.57	-0.78	0.68	-0.82	0.68	0.68	0.71
Accounts Payable	0.8	0.77	-0.69	-0.65		0.01	0.73	-0.67	0.13	0.74	0.78	0.76	-0.76	-0.74	0.7	0.33	-0.17	0.4	-0.17	-0.17	-0.16
Total Liab	-0.26	-0.41	0.34	0.48	0.01		-0.25	0.35	0.47	-0.21	-0.1	-0.43	0.42	0.48	-0.24	-0.65	0.67	-0.4	0.67	0.67	0.68
Total Current Assets	0.96	0.93	-0.96	-0.66	0.73	-0.25		-0.77	-0.08	0.97	0.93	0.89	-0.83	-0.82	0.98	0.53	-0.27	0.27	-0.27	-0.27	-0.29
Short Term Debt	-0.86	-0.89	0.9	0.74	-0.67	0.35	-0.77		0.49	-0.82	-0.81	-0.94	0.93	0.94	-0.81	-0.67	0.43	-0.57	0.43	0.43	0.44
Common Stock	-0.13	-0.18	0.26	-0.01	0.13	0.47	-0.08	0.49		-0.17	0.04	-0.27	0.23	0.31	-0.21	-0.18	0.14	-0.18	0.14	0.14	0.14
Net Receivables	0.93	0.9	-0.97	-0.59	0.74	-0.21	0.97	-0.82	-0.17		0.92	0.88	-0.83	-0.82	0.97	0.56	-0.2	0.18	-0.2	-0.2	-0.2
Net Tangible Assets	0.95	0.92	-0.91	-0.76	0.78	-0.1	0.93	-0.81	0.04	0.92		0.9	-0.89	-0.85	0.88	0.6	-0.3	0.39	-0.3	-0.3	-0.3
Net Invested Capital	0.95	0.99	-0.95	-0.86	0.76	-0.43	0.89	-0.94	-0.27	0.88	0.9		-0.98	-0.98	0.88	0.7	-0.52	0.6	-0.52	-0.52	-0.54
Short Long Term Debt	-0.92	-0.96	0.9	0.91	-0.76	0.42	-0.83	0.93	0.23	-0.83	-0.89	-0.98		1.0	-0.8	-0.77	0.51	-0.67	0.51	0.51	0.52
Capital Stock	-0.91	-0.95	0.89	0.89	-0.74	0.48	-0.82	0.94	0.31	-0.82	-0.85	-0.98	1.0		-0.8	-0.77	0.52	-0.68	0.52	0.52	0.54
Net Working Capital	0.93	0.91	-0.97	-0.57	0.7	-0.24	0.98	-0.81	-0.21	0.97	0.88	0.88	-0.8	-0.8		0.47	-0.26	0.2	-0.26	-0.26	-0.27
Current Deferred Revenue	0.55	0.67	-0.64	-0.78	0.33	-0.65	0.53	-0.67	-0.18	0.56	0.6	0.7	-0.77	-0.77	0.47		-0.61	0.5	-0.61	-0.61	-0.61
Deferred Long Term Liab	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61		-0.58	1.0	1.0	0.99
Property Plant Equipment	0.5	0.55	-0.35	-0.82	0.4	-0.4	0.27	-0.57	-0.18	0.18	0.39	0.6	-0.67	-0.68	0.2	0.5	-0.58		-0.58	-0.58	-0.63
Long Term Debt	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58		1.0	0.99
Short Term Investments	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58	1.0		0.99
Intangible Assets	-0.35	-0.54	0.41	0.71	-0.16	0.68	-0.29	0.44	0.14	-0.2	-0.3	-0.54	0.52	0.54	-0.27	-0.61	0.99	-0.63	0.99	0.99

Click cells to compare fundamentals

Intelligent Total Debt Historical Pattern

Today, most investors in Intelligent Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intelligent Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Intelligent Bio total debt as a starting point in their analysis.

Intelligent Bio Total Debt

Timeline

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Competition

Predict Intelligent Bio

Short Long Term Debt Total Over Time

Intelligent Short Long Term Debt Total

Short Long Term Debt Total

827,868

At this time, Intelligent Bio's Short and Long Term Debt Total is comparatively stable compared to the past year.

Based on the latest financial disclosure, Intelligent Bio Solutions has a Total Debt of 871.44 K. This is 99.97% lower than that of the Health Care Equipment & Supplies sector and 99.91% lower than that of the Health Care industry. The total debt for all United States stocks is 99.98% higher than that of the company.

Intelligent Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.

Intelligent Bio is currently under evaluation in total debt category among its peers.

Intelligent Bio Institutional Holders

Institutional Holdings refers to the ownership stake in Intelligent Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intelligent Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intelligent Bio's value.

		Shares
Citigroup Inc	2024-06-30	0.0
Headlands Technologies Llc	2024-06-30	0.0
Jpmorgan Chase & Co	2024-06-30	0.0
Virtu Financial Llc	2024-06-30	0.0
Alyeska Investment Group, L.p.	2024-09-30	206.2 K
Cvi Holdings Llc	2024-06-30	79.8 K
Geode Capital Management, Llc	2024-09-30	22.7 K
Vanguard Group Inc	2024-09-30	15.5 K
Ubs Group Ag	2024-06-30	8.3 K
Adar1 Capital Management Llc	2024-09-30	5.4 K
Tower Research Capital Llc	2024-06-30	654

Intelligent Fundamentals

	Return On Equity	-1.72
	Return On Asset	-0.53
	Operating Margin	(3.86) %
	Current Valuation	3.44 M
	Shares Outstanding	4.39 M
	Shares Owned By Insiders	3.01 %
	Shares Owned By Institutions	14.38 %
	Number Of Shares Shorted	420.64 K
	Price To Book	1.09 X
	Price To Sales	2.13 X
	Revenue	3.11 M
	Gross Profit	326.67 K
	EBITDA	(8.81 M)
	Net Income	(10.19 M)
	Cash And Equivalents	8.28 M
	Cash Per Share	0.56 X
	Total Debt	871.44 K
	Current Ratio	2.33 X
	Book Value Per Share	2.41 X
	Cash Flow From Operations	(9.57 M)
	Short Ratio	1.25 X
	Earnings Per Share	(2.30) X
	Target Price	12.0
	Number Of Employees	50
	Beta	4.72
	Market Capitalization	6.14 M
	Total Asset	13.78 M
	Retained Earnings	(51.96 M)
	Working Capital	3.08 M
	Net Asset	13.78 M

About Intelligent Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC